MYO9A and diabetic kidney disease: Alternatively, hyperglycemia and VEGF164-induced NOS uncoupling reduce NO availability (17), which in turn could influence Myo9A expression and SNO-Myo9A in diabetic glomeruli and thereby contribute to DKD progression.